Zecotek Photonics (ZMSPF) 0.2195 $ZMSPF
OEM Orders LFS Scintillation Crystals For Silo and Container Measurement
PR Newswire - Mon Aug 15, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that a world leader in the area of level, switching and pressure measurement for the process industry, has ordered LFS scintillation crystals for a leading edge approach to the measurement of silos and large containers. The device is able to detect the level of liquids, pastes, powders and bulk solids in silos and large containers and is to be widely deployed in industries such as oil and gas, chemical, and waste management.
ZMS.VN: 0.285 (-0.005)
Zecotek Announces Non-Brokered Private Placement
ACCESSWIRE - Fri Aug 12, 10:06PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / August 12, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has arranged for a non-brokered private placement of 2,750,000 units of the Company at a price of $0.30 per unit for gross proceeds of $825,000.
ZMS.VN: 0.285 (-0.005)
Chinese OEM Successfully Assembles First Positron Emission Tomography Medical Scanner and Orders LFS Scintillation Crystals for Second Unit
CNW Group - Thu Jul 28, 4:00PM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices, has assembled the first PET medical scanner for testing and has ordered Zecotek`s patented LFS crystals for a second unit. As previously announced on March 23, 2016, Zecotek Imaging Systems signed a memorandum of understanding (MOU) with the medical OEM to purchase LFS scintillation crystals for a new line of medical scanners. The OEM is now projecting the installation of up to 5 LFS based PET scanners by year end and 200 scanners over the next five years in hospitals and clinics across China. For competitive reasons the OEM has requested to remain anonymous until the contract is in effect.
ZMS.VN: 0.285 (-0.005)
Zecotek Closes Non-Brokered Private Placement
ACCESSWIRE - Mon Jun 20, 7:46PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / June 20, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has closed on the second tranche of the private placement, previously announced on May 9, 2016, by selling 2,989,330 units of the Company at a price of $0.30 per unit for gross proceeds of $896,799. The Company sold an aggregate of 5,249,330 units at a price of $0.30 for total gross proceeds of $1,574,799.
ZMS.VN: 0.285 (-0.005)
Zecotek Increases Non-Brokered Private Placement to $1,574,799
ACCESSWIRE - Tue Jun 14, 6:09PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / June 14, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement, announced on May 9, 2016, to $1,574,799.
ZMS.VN: 0.285 (-0.005)
Zecotek Increases Non-Brokered Private Placement to $925,000 and Closes First Tranche of $678,000
ACCESSWIRE - Thu May 26, 8:12AM CDT
SINGAPORE / ACCESSWIRE / May 26, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I) (the "Company"
, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement announced on May 19, 2016 to $925,000. The Company also announced it has closed on the first tranche of the private placement by selling 2,259,997 units of the Company at a price of $0.30 per unit for gross proceeds of $678,000.
ZMS.VN: 0.285 (-0.005)
Chinese OEM Receives First Order of Patented LFS Scintillation Crystals
PR Newswire - Thu May 05, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices, has received the first order of LFS scintillation crystals. As previously announced on March 23, 2016, Zecotek Imaging Systems signed a memorandum of understanding (MOU) with the medical OEM to purchase LFS scintillation crystals. The MOU contains two conditions that when met, will lead to a contractual agreement. The first condition is the delivery and receipt of the LFS crystals by the end of April 2016, and the second is the installation of the first LFS based PET scanner in a Shanghai clinic by early summer.
ZMS.VN: 0.285 (-0.005)
Zecotek Reports $685,452 of LFS Scintillation Crystal Sales Revenue For Third Quarter Fiscal 2016
CNW Group - Fri Apr 29, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today reported preliminary unaudited revenue for the third quarter ending April 30, 2016. Sales for the third quarter were $685,452, a ninefold increase from $70,149 posted in the same time period last year. Unaudited revenue for the nine months ending April 30, 2016 increased $1,288,726 to $1,532,406 from $243,680 in fiscal 2015.
ZMS.VN: 0.285 (-0.005)
PET Program at CERN Selects and Orders LFS Crystals
CNW Group - Thu Apr 21, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the Positron Emission Tomography (PET) program at European Organization for Nuclear Physics (CERN) has selected and ordered its patented LFS scintillation crystals for its work on PET medical scanning devices. After a long process of testing, Zecotek`s LFS scintillation crystals were chosen because they provide the best results for coincidence timing resolution. The LFS technology and formulation also present an intrinsic capability and ability for the future development of even higher performance LFS versions as compared to any competing crystals.
ZMS.VN: 0.285 (-0.005)
Zecotek Receives First Patent for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystals
PR Newswire - Wed Apr 06, 8:26AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned division, Zecotek Imaging Systems Pte. Ltd., has been granted its first patent in a series of pending patents for its advanced formulation of its patented LFS scintillation crystals. The patent is for multi-doped lutetium oxide based scintillators having improved photonic properties.
ZMS.VN: 0.285 (-0.005)
OEM Orders LFS Scintillation Crystals For Silo and Container Measurement
PR Newswire - Mon Aug 15, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that a world leader in the area of level, switching and pressure measurement for the process industry, has ordered LFS scintillation crystals for a leading edge approach to the measurement of silos and large containers. The device is able to detect the level of liquids, pastes, powders and bulk solids in silos and large containers and is to be widely deployed in industries such as oil and gas, chemical, and waste management.
ZMS.VN: 0.285 (-0.005)
Zecotek Announces Non-Brokered Private Placement
ACCESSWIRE - Fri Aug 12, 10:06PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / August 12, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has arranged for a non-brokered private placement of 2,750,000 units of the Company at a price of $0.30 per unit for gross proceeds of $825,000.
ZMS.VN: 0.285 (-0.005)
Chinese OEM Successfully Assembles First Positron Emission Tomography Medical Scanner and Orders LFS Scintillation Crystals for Second Unit
CNW Group - Thu Jul 28, 4:00PM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices, has assembled the first PET medical scanner for testing and has ordered Zecotek`s patented LFS crystals for a second unit. As previously announced on March 23, 2016, Zecotek Imaging Systems signed a memorandum of understanding (MOU) with the medical OEM to purchase LFS scintillation crystals for a new line of medical scanners. The OEM is now projecting the installation of up to 5 LFS based PET scanners by year end and 200 scanners over the next five years in hospitals and clinics across China. For competitive reasons the OEM has requested to remain anonymous until the contract is in effect.
ZMS.VN: 0.285 (-0.005)
Zecotek Closes Non-Brokered Private Placement
ACCESSWIRE - Mon Jun 20, 7:46PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / June 20, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has closed on the second tranche of the private placement, previously announced on May 9, 2016, by selling 2,989,330 units of the Company at a price of $0.30 per unit for gross proceeds of $896,799. The Company sold an aggregate of 5,249,330 units at a price of $0.30 for total gross proceeds of $1,574,799.
ZMS.VN: 0.285 (-0.005)
Zecotek Increases Non-Brokered Private Placement to $1,574,799
ACCESSWIRE - Tue Jun 14, 6:09PM CDT
SINGAPORE, SINGAPORE / ACCESSWIRE / June 14, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement, announced on May 9, 2016, to $1,574,799.
ZMS.VN: 0.285 (-0.005)
Zecotek Increases Non-Brokered Private Placement to $925,000 and Closes First Tranche of $678,000
ACCESSWIRE - Thu May 26, 8:12AM CDT
SINGAPORE / ACCESSWIRE / May 26, 2016 / Zecotek Photonics Inc. (TSXV: ZMS) (FSE: W1I) (the "Company"
, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increased the non-brokered private placement announced on May 19, 2016 to $925,000. The Company also announced it has closed on the first tranche of the private placement by selling 2,259,997 units of the Company at a price of $0.30 per unit for gross proceeds of $678,000. ZMS.VN: 0.285 (-0.005)
Chinese OEM Receives First Order of Patented LFS Scintillation Crystals
PR Newswire - Thu May 05, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the major medical OEM based in China, which selected Zecotek's patented lutetium fine silicate (LFS) scintillation crystals for a new line of high resolution positron emission tomography (PET) medical imaging devices, has received the first order of LFS scintillation crystals. As previously announced on March 23, 2016, Zecotek Imaging Systems signed a memorandum of understanding (MOU) with the medical OEM to purchase LFS scintillation crystals. The MOU contains two conditions that when met, will lead to a contractual agreement. The first condition is the delivery and receipt of the LFS crystals by the end of April 2016, and the second is the installation of the first LFS based PET scanner in a Shanghai clinic by early summer.
ZMS.VN: 0.285 (-0.005)
Zecotek Reports $685,452 of LFS Scintillation Crystal Sales Revenue For Third Quarter Fiscal 2016
CNW Group - Fri Apr 29, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today reported preliminary unaudited revenue for the third quarter ending April 30, 2016. Sales for the third quarter were $685,452, a ninefold increase from $70,149 posted in the same time period last year. Unaudited revenue for the nine months ending April 30, 2016 increased $1,288,726 to $1,532,406 from $243,680 in fiscal 2015.
ZMS.VN: 0.285 (-0.005)
PET Program at CERN Selects and Orders LFS Crystals
CNW Group - Thu Apr 21, 8:00AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the Positron Emission Tomography (PET) program at European Organization for Nuclear Physics (CERN) has selected and ordered its patented LFS scintillation crystals for its work on PET medical scanning devices. After a long process of testing, Zecotek`s LFS scintillation crystals were chosen because they provide the best results for coincidence timing resolution. The LFS technology and formulation also present an intrinsic capability and ability for the future development of even higher performance LFS versions as compared to any competing crystals.
ZMS.VN: 0.285 (-0.005)
Zecotek Receives First Patent for New Advanced Formulation of its Worldwide Patented LFS Scintillation Crystals
PR Newswire - Wed Apr 06, 8:26AM CDT
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that its wholly owned division, Zecotek Imaging Systems Pte. Ltd., has been granted its first patent in a series of pending patents for its advanced formulation of its patented LFS scintillation crystals. The patent is for multi-doped lutetium oxide based scintillators having improved photonic properties.
ZMS.VN: 0.285 (-0.005)
